The story of the blue pill offers a intricate case study for investors eyeing pharma. While initial sales were astounding, recent patent expiry and the arrival of cheaper versions have considerably influenced revenues. https://minapimz433926.blogdun.com/41720516/viagra-and-the-pharmaceutical-industry-a-dangerous-bet